PAIP2

gene
On this page

Also known as PAIP2A

Summary

PAIP2 (poly(A) binding protein interacting protein 2, HGNC:17970) is a protein-coding gene on chromosome 5q31.2, encoding Polyadenylate-binding protein-interacting protein 2 (Q9BPZ3). Acts as a repressor in the regulation of translation initiation of poly(A)-containing mRNAs.

Enables translation repressor activity. Involved in negative regulation of translational initiation. Located in cytoplasm.

Source: NCBI Gene 51247 — RefSeq curated summary.

At a glance

  • GWAS associations: 6
  • Clinical variants (ClinVar): 18 total
  • MANE Select transcript: NM_016480

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:17970
Approved symbolPAIP2
Namepoly(A) binding protein interacting protein 2
Location5q31.2
Locus typegene with protein product
StatusApproved
AliasesPAIP2A
Ensembl geneENSG00000120727
Ensembl biotypeprotein_coding
OMIM605604
Entrez51247

Gene structure

Transcript identifiers

Ensembl transcripts: 23 — 20 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000265192, ENST00000394795, ENST00000507415, ENST00000507755, ENST00000510080, ENST00000510409, ENST00000511381, ENST00000511706, ENST00000881921, ENST00000881922, ENST00000881923, ENST00000917509, ENST00000917510, ENST00000917511, ENST00000917512, ENST00000917513, ENST00000917514, ENST00000917515, ENST00000917516, ENST00000954475, ENST00000954476, ENST00000954477, ENST00000954478

RefSeq mRNA: 2 — MANE Select: NM_016480 NM_001033112, NM_016480

CCDS: CCDS4211

Canonical transcript exons

ENST00000265192 — 4 exons

ExonStartEnd
ENSE00001425481139341854139341980
ENSE00001898705139368733139369717
ENSE00003513430139364564139364743
ENSE00003561860139363759139363922

Expression profiles

Bgee: expression breadth ubiquitous, 268 present calls, max score 99.78.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 83.9466 / max 910.9452, expressed in 1822 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
5882483.82351822
588270.072220
588260.03185
588250.01915

Top tissues by expression

268 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cardiac muscle of right atriumUBERON:000337999.78gold quality
left ventricle myocardiumUBERON:000656699.77gold quality
cerebellar vermisUBERON:000472099.44gold quality
ponsUBERON:000098899.36gold quality
myocardiumUBERON:000234999.35gold quality
kidney epitheliumUBERON:000481999.26gold quality
thymusUBERON:000237099.15gold quality
deltoidUBERON:000147699.10gold quality
tibialis anteriorUBERON:000138599.08gold quality
cartilage tissueUBERON:000241899.05gold quality
postcentral gyrusUBERON:000258199.05gold quality
upper arm skinUBERON:000426399.02gold quality
embryoUBERON:000092299.01gold quality
ganglionic eminenceUBERON:000402399.01gold quality
quadriceps femorisUBERON:000137798.99gold quality
superior vestibular nucleusUBERON:000722798.95gold quality
parotid glandUBERON:000183198.94gold quality
vastus lateralisUBERON:000137998.93gold quality
superior frontal gyrusUBERON:000266198.89gold quality
parietal lobeUBERON:000187298.88gold quality
substantia nigra pars compactaUBERON:000196598.87gold quality
heart right ventricleUBERON:000208098.82gold quality
substantia nigra pars reticulataUBERON:000196698.77gold quality
substantia nigraUBERON:000203898.72gold quality
monocyteCL:000057698.71gold quality
prefrontal cortexUBERON:000045198.71gold quality
ventricular zoneUBERON:000305398.71gold quality
midbrainUBERON:000189198.70gold quality
hypothalamusUBERON:000189898.69gold quality
leukocyteCL:000073898.65gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ENAD-17no632.15
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

99 targeting PAIP2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-429100.0073.442698
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-29A-3P100.0073.111835
HSA-MIR-29B-3P100.0073.181833
HSA-MIR-29C-3P100.0073.151833
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-477599.9875.006394
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-568899.9673.234504
HSA-MIR-495-3P99.9672.814197
HSA-MIR-590-3P99.9674.346478
HSA-MIR-365899.9673.874379
HSA-MIR-128-3P99.9571.172484
HSA-MIR-216A-3P99.9571.192505
HSA-MIR-144-3P99.9473.982698
HSA-MIR-539-5P99.9370.302855
HSA-MIR-218-5P99.9372.222103
HSA-MIR-338-5P99.9272.342951
HSA-MIR-130599.9171.433443
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-498-3P99.9171.271114
HSA-MIR-430299.8967.941187
HSA-MIR-3681-3P99.8870.462254

Literature-anchored findings (GeneRIF, showing 5)

  • Role of PAIP2 in modulation of GLUT5 mRNA stability. (PMID:12820898)
  • PAIP2 is a crucial regulator of VEGF mRNA and has a role in regulating angiogenesis (PMID:15175342)
  • The turnover of Paip2 in the cell is mediated by EDD and is regulated by PABP. (PMID:16601676)
  • Paip2 is a host antiviral restriction factor antagonized by PABP accumulation in HCMV-infected cells (PMID:23964095)
  • These results indicated that PAIP1 and PAIP2 participate in translation termination and are important regulators of readthrough at the premature termination codon. (PMID:30992367)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
mus_musculusPaip2ENSMUSG00000037058
rattus_norvegicusPaip2ENSRNOG00000019934
drosophila_melanogasterPaip2FBGN0038100

Paralogs (1): PAIP2B (ENSG00000124374)

Protein

Protein identifiers

Polyadenylate-binding protein-interacting protein 2Q9BPZ3 (reviewed: Q9BPZ3)

All UniProt accessions (3): D6R9Y1, D6RA77, Q9BPZ3

UniProt curated annotations — full annotation on UniProt →

Function. Acts as a repressor in the regulation of translation initiation of poly(A)-containing mRNAs. Its inhibitory activity on translation is mediated via its action on PABPC1. Displaces the interaction of PABPC1 with poly(A) RNA and competes with PAIP1 for binding to PABPC1. Its association with PABPC1 results in disruption of the cytoplasmic poly(A) RNP structure organization.

Subunit / interactions. Interacts with the second and third RRM domains and C-terminus regions of PABPC1 in a 2:1 stoichiometry.

Subcellular location. Cytoplasm.

Tissue specificity. Expressed at highest level in testis, but also abundant in brain, cervix, lung, ovary, placenta, adipose tissue, thymus and thyroid.

Post-translational modifications. Ubiquitinated, leading to its degradation by the proteasome.

Domain organisation. Only the PABPC1-interacting motif-1 (PAM1) interferes with the binding of PABPC1 to poly(A) RNA and translation initiation.

Similarity. Belongs to the PAIP2 family.

RefSeq proteins (2): NP_001028284, NP_057564* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR009818PAM2_motifConserved_site
IPR040396PAIP2-likeFamily

Pfam: PF07145

UniProt features (7 total): region of interest 3, sequence conflict 2, chain 1, compositionally biased region 1

Structure

Experimental structures (PDB)

3 structures.

PDBMethodResolution (Å)
3KUSX-RAY DIFFRACTION1.4
3KUTX-RAY DIFFRACTION1.5
1JGNSOLUTION NMR

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BPZ3-F172.020.26

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-9820841M-decay: degradation of maternal mRNAs by maternally stored factors

MSigDB gene sets: 205 (showing top): GOBP_MEMORY, TGGTGCT_MIR29A_MIR29B_MIR29C, GOBP_COGNITION, GOBP_BEHAVIOR, GOBP_TRANSLATIONAL_INITIATION, AP2_Q3, GOBP_MALE_GAMETE_GENERATION, GOBP_NEGATIVE_REGULATION_OF_TRANSLATION, GOBP_CELL_CELL_SIGNALING, GOBP_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, GOMF_TRANSLATION_REGULATOR_ACTIVITY, GOBP_REGULATION_OF_SYNAPTIC_PLASTICITY, OCT1_03

GO Biological Process (7): translation (GO:0006412), spermatogenesis (GO:0007283), memory (GO:0007613), negative regulation of translation (GO:0017148), negative regulation of translational initiation (GO:0045947), regulation of long-term synaptic potentiation (GO:1900271), regulation of translation (GO:0006417)

GO Molecular Function (4): mRNA regulatory element binding translation repressor activity (GO:0000900), mRNA binding (GO:0003729), translation repressor activity (GO:0030371), protein binding (GO:0005515)

GO Cellular Component (1): cytoplasm (GO:0005737)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Maternal to zygotic transition (MZT)1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
translational initiation2
translation2
negative regulation of translation2
peptidyltransferase activity1
translational elongation1
translational termination1
macromolecule biosynthetic process1
protein metabolic process1
protein biosynthetic process1
developmental process involved in reproduction1
male gamete generation1
learning or memory1
regulation of translation1
negative regulation of gene expression1
negative regulation of protein metabolic process1
regulation of translational initiation1
regulation of synaptic plasticity1
long-term synaptic potentiation1
post-transcriptional regulation of gene expression1
regulation of protein metabolic process1
mRNA binding1
translation repressor activity1
RNA binding1
translation regulator activity1
binding1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

842 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PAIP2PABPC1P11940977
PAIP2PAIP1Q9H074940
PAIP2EIF4G1Q04637783
PAIP2ELAVL1Q15717772
PAIP2EIF3JO75822768
PAIP2ANKRD52Q8NB46671
PAIP2RRM2P31350560
PAIP2PABPC4Q13310559
PAIP2PABPC1LQ4VXU2554
PAIP2PABPC5Q96DU9541
PAIP2PABPC3Q9H361521
PAIP2HNRNPLP14866466
PAIP2PABPC4LP0CB38460
PAIP2EIF4EP06730454
PAIP2PABPC1L2AQ5JQF8452

IntAct

60 interactions, top by confidence:

ABTypeScore
PAIP2PABPC1psi-mi:“MI:0915”(physical association)0.860
PABPC1PAIP2psi-mi:“MI:0407”(direct interaction)0.860
PABPC1PAIP2psi-mi:“MI:0915”(physical association)0.860
PAIP2PABPC1psi-mi:“MI:0407”(direct interaction)0.860
NPABPC1psi-mi:“MI:0915”(physical association)0.700
PAIP2UBR5psi-mi:“MI:0915”(physical association)0.680
PAIP2UBR5psi-mi:“MI:0407”(direct interaction)0.680
UBR5PAIP2psi-mi:“MI:0407”(direct interaction)0.680
UBR5PAIP2psi-mi:“MI:0220”(ubiquitination reaction)0.680
PABPC5PAIP2psi-mi:“MI:0915”(physical association)0.670
DNALI1PAIP2psi-mi:“MI:0915”(physical association)0.560
KLF11PAIP2psi-mi:“MI:0915”(physical association)0.560
PAIP2NUP58psi-mi:“MI:0915”(physical association)0.560
PABPC1P/V/Cpsi-mi:“MI:0915”(physical association)0.520
PAIP2NDNpsi-mi:“MI:0915”(physical association)0.470
PABPC1P/V/Cpsi-mi:“MI:0915”(physical association)0.400

BioGRID (94): PAIP2 (Affinity Capture-RNA), PAIP2 (Affinity Capture-MS), PAIP2 (Affinity Capture-MS), PAIP2 (Affinity Capture-MS), PAIP2 (Affinity Capture-MS), PAIP2 (Reconstituted Complex), PAIP2 (Reconstituted Complex), PAIP2 (Affinity Capture-MS), PAIP2 (Affinity Capture-MS), PAIP2 (Affinity Capture-MS), PAIP2 (Affinity Capture-RNA), PAIP2 (Affinity Capture-MS), PAIP2 (Affinity Capture-MS), PABPC5 (Two-hybrid), PAIP2 (Proximity Label-MS)

ESM2 similar proteins: A1YEW9, A2D4U8, A2D5N1, A2D671, A2T6K9, A8MQL1, B8AE37, F4HY56, G3V9A7, O23116, O60238, P48785, P79149, Q0DKP4, Q15170, Q15361, Q15390, Q1PEB4, Q2KIJ9, Q3T013, Q3ULM0, Q3ZBJ9, Q5H9J7, Q5PPP3, Q5PR69, Q5RFN3, Q5XVC4, Q67XL4, Q6K678, Q7XRV0, Q86X53, Q8GYL9, Q8GZ92, Q8RY18, Q91W45, Q921P9, Q94F39, Q96GX8, Q99MB2, Q9AV50

Diamond homologs: Q3ZC67, Q5R596, Q5ZJS6, Q6AXZ0, Q91W45, Q9BPZ3, Q9D6V8, Q9ULR5

SIGNOR signaling

1 interactions.

AEffectBMechanism
UBR5“down-regulates quantity by destabilization”PAIP2polyubiquitination

Disease & clinical

Clinical variants and AI predictions

ClinVar

18 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance15
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

781 predictions. Top by Δscore:

VariantEffectΔscore
5:139363757:A:Gacceptor_gain1.0000
5:139363905:G:GTdonor_gain1.0000
5:139363918:GACAA:Gdonor_gain1.0000
5:139363920:CAAG:Cdonor_loss1.0000
5:139363923:G:GGdonor_gain1.0000
5:139363924:T:Gdonor_gain1.0000
5:139364732:G:GTdonor_gain1.0000
5:139341945:GA:Gdonor_gain0.9900
5:139341979:GG:Gdonor_gain0.9900
5:139341980:GG:Gdonor_gain0.9900
5:139341980:GGT:Gdonor_loss0.9900
5:139341981:GT:Gdonor_loss0.9900
5:139341982:T:Gdonor_loss0.9900
5:139342054:GGGCC:Gdonor_gain0.9900
5:139363756:AAG:Aacceptor_gain0.9900
5:139363758:G:Aacceptor_gain0.9900
5:139363758:G:GCacceptor_loss0.9900
5:139363758:G:GGacceptor_gain0.9900
5:139363758:GGTTA:Gacceptor_gain0.9900
5:139363919:A:Gdonor_gain0.9900
5:139363919:ACAA:Adonor_gain0.9900
5:139363921:AA:Adonor_gain0.9900
5:139363925:TAGTT:Tdonor_loss0.9900
5:139364556:A:AGacceptor_gain0.9900
5:139364557:A:Gacceptor_gain0.9900
5:139364560:CTA:Cacceptor_loss0.9900
5:139364561:TA:Tacceptor_loss0.9900
5:139364562:A:AGacceptor_gain0.9900
5:139364563:G:GGacceptor_gain0.9900
5:139364563:G:Tacceptor_loss0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000013410 (5:139363668 A>C), RS1000185574 (5:139345869 C>T), RS1000212599 (5:139360361 C>G), RS1000217972 (5:139345616 C>T), RS1000383563 (5:139340283 A>C,T), RS1000409692 (5:139340579 C>A,G), RS1000501105 (5:139364153 A>C), RS1000522816 (5:139347238 C>T), RS1000607282 (5:139357080 C>G), RS1000709632 (5:139353196 T>C), RS1000728620 (5:139352931 C>T), RS1000772632 (5:139351607 A>G), RS1000813100 (5:139359151 T>A), RS1000889839 (5:139344656 A>G), RS1001007084 (5:139346964 C>G)

Disease associations

OMIM: gene MIM:605604 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

6 associations (top):

StudyTraitp-value
GCST005951_151Body mass index6.000000e-07
GCST010725_68Malaria4.000000e-07
GCST010725_7Malaria2.000000e-06
GCST90002385_347High light scatter reticulocyte count2.000000e-11
GCST90002386_41High light scatter reticulocyte percentage of red cells9.000000e-11
GCST90002387_310Immature fraction of reticulocytes1.000000e-09

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004340body mass index
EFO:0007986reticulocyte count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

32 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases expression, increases expression, affects cotreatment3
aristolochic acid Idecreases expression1
bisphenol Fincreases expression1
dicrotophosdecreases expression1
triphenyl phosphateaffects expression1
sodium arseniteincreases expression1
cupric oxideincreases expression1
ICG 001increases expression1
abrinedecreases expression1
jinfukangdecreases expression1
bisphenol AFincreases expression1
Air Pollutantsaffects expression, increases abundance1
Ethanolaffects cotreatment, decreases expression, increases abundance1
Arsenicaffects methylation1
Benzo(a)pyreneincreases methylation1
Bile Acids and Saltsincreases expression1
Dexamethasoneaffects cotreatment, increases expression1
Estradioldecreases expression1
Ethyl Methanesulfonateincreases expression1
Fructoseaffects binding, increases reaction1
Gasolinedecreases expression, increases abundance, affects cotreatment1
Glucoseaffects binding, increases reaction1
Indomethacinaffects cotreatment, increases expression1
Methyl Methanesulfonateincreases expression1
Ozoneaffects expression, increases abundance1
Polycyclic Aromatic Hydrocarbonsaffects cotreatment, decreases expression, increases abundance1
Potassium Dichromateincreases expression1
Tobacco Smoke Pollutionincreases expression1
Tretinoindecreases expression1
Valproic Aciddecreases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B3D9Abcam HEK293T PAIP2 KOTransformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.